Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$43.23 - $73.83 $2,680 - $4,577
-62 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$53.19 - $79.24 $3,297 - $4,912
62 New
62 $4,000
Q4 2021

Feb 15, 2022

SELL
$70.09 - $111.29 $4,345 - $6,899
-62 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$110.2 - $156.64 $20,497 - $29,135
-186 Reduced 75.0%
62 $7,000
Q4 2020

Feb 18, 2021

BUY
$79.67 - $173.23 $14,818 - $32,220
186 Added 300.0%
248 $38,000
Q3 2020

Nov 16, 2020

BUY
$78.5 - $100.64 $4,867 - $6,239
62 New
62 $5,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.15B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Capital Advisory Group Advisory Services, LLC Portfolio

Follow Capital Advisory Group Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.